Clinical Trials Insight: 700031614

Trial Profile

Clinical Trials Insight: 700031614

Phase of Trial: Phase III

Latest Information Update: 07 Apr 2008

At a glance

  • Drugs Creatine monohydrate (Primary)
  • Indications Huntington's disease
  • Focus Registrational; Therapeutic Use
  • Sponsors Avicena Group
  • Most Recent Events

    • 07 Apr 2008 Enrolment is expected to be initiated in the third quater of 2008.
    • 17 Mar 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top